Aripiprazole as an Augmentation Agent in Treatment-Resistant Body Dysmorphic Disorder

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.30, Iss.10, 2010-10, pp. : 707-710

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aripiprazole Augmentation of Clozapine in Treatment-Resistant Schizophrenia: A Clinical Observation

By Ziegenbein Marc

Clinical Drug Investigation, Vol. 26, Iss. 3, 2006-01 ,pp. : 117-124

Adis International

Access to resources Recommend Favorite

Aripiprazole Addition to Serotonin Reuptake Inhibitor in Treatment-Resistant Obsessive-Compulsive Disorder

By Shoja Shafti Saeed

Current Psychopharmacology, Vol. 3, Iss. 3, 2014-12 ,pp. : 219-225

Bentham Science Publishers

Access to resources Recommend Favorite

Aripiprazole Addition to Serotonin Reuptake Inhibitor in Treatment-Resistant Obsessive-Compulsive Disorder

Current Psychopharmacology, Vol. 3, Iss. 3, 2014-12 ,pp. : 219-225

Bentham Science Publishers

Access to resources Recommend Favorite

Sequential administration of augmentation strategies in treatment-resistant obsessive compulsive disorder

By Blier P. Bergeron R. Heacute bert C.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 370-370

Elsevier

Access to resources Recommend Favorite

Pharmacological augmentation strategies for treatment-resistant obsessive-compulsive disorder

By Walsh Kelda H McDougle Christopher J

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 10, 2004-10 ,pp. : 2059-2067

Informa Healthcare

Access to resources Recommend Favorite